Company news
TSO3 Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
TSO3 Inc. Announces Completion of Arrangement
October 1, 2019
TSO3 Inc. announces receipt of final Court approval for Plan of Arrangement with Stryker
September 26, 2019
TSO3 Inc. Shareholders Approve Plan of Arrangement with Stryker
September 23, 2019
TSO3 Inc. Confirms Purchase Price of CAD $0.43 per Share
September 19, 2019
TSO3 Inc. reminds shareholders to vote for the arrangement with Stryker
September 12, 2019
TSO3 Inc. Announces the Filing of its Circular in Connection with the Special Meeting of Shareholders and Reminds Shareholders of the Key Reasons Why the Board Recommends Shareholders to Vote for the Arrangement with Stryker
August 23, 2019
TSO3 Reports Second Quarter 2019 Results
August 12, 2019
TSO3 Inc. Enters into Agreement to be Acquired by Stryker Corporation
August 12, 2019
TSO3 Announces Group Purchasing Agreement with Capstone Health Alliance
June 11, 2019
TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders
May 8, 2019
TSO3 Reports First Quarter 2019 Results
May 6, 2019
TSO3 Announces the Dates of its First Quarter 2019 Earnings Conference Call and Annual General Meeting of Shareholders
April 30, 2019
TSO3 Announces Changes to the Board of Directors
April 2, 2019
TSO3 Reports Fourth Quarter and Full Year 2018 Results
March 27, 2019
TSO3 Announces Date of Fourth Quarter and Full Year 2018 Earnings Conference Call
March 21, 2019
TSO3 Expands Duodenoscope Sterilization Testing
March 14, 2019
TSO3 Achieves Commercial Milestone and Provides Operational Update
January 7, 2019
American Journal of Infection Control publishes TSO3 study on terminal sterilization of duodenoscopes
November 15, 2018
TSO3 Reports Third Quarter 2018 Results
November 6, 2018
TSO3 Awarded Low Temperature Sterilization Contract pursuant to a Quebec Tender
October 30, 2018
TSO3 Named Winner of South Carolina Innovation Award
October 29, 2018
TSO3 to Report Third Quarter 2018 Results on Wednesday, November 7, 2018
October 25, 2018
TSO3 Provides a Commercialization Update
October 4, 2018
TSO3 Appoints Martin J. Madden to the Board of Directors
August 29, 2018
UCHealth performs first patient procedure in Colorado using STERIZONE® technology
August 20, 2018
TSO3 Reports Second Quarter 2018 Results
August 7, 2018
TSO3 Announces Closing of US$20 million Financing with Courage Capital to Commercialize the STERIZONE® VP4 Sterilizer and Support Getinge Transition
August 1, 2018
TSO3 to Report Second Quarter 2018 Results on Wednesday, August 8, 2018
July 30, 2018
Altru® Health System Improves Patient Care with Expanded Use of Cutting-Edge Sterilization Technology
June 14, 2018
TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders and the Appointment New Chairperson
May 10, 2018
TSO3 Obtains New Clearance for the STERIZONE® VP4 Sterilizer
May 9, 2018
TSO3 Reports First Quarter 2018 Results
May 8, 2018
TSO3 to Report First Quarter 2018 Results and Hold Annual Meeting of Shareholders on Wednesday, May 9, 2018
April 30, 2018
TSO3 's Chief Science Officer to moderate Educational Panel at the IAHCSMM Annual Congress
April 26, 2018
TSO3 Details Results of Prion Inactivation Studies
April 26, 2018
TSO3 Appoints Dr. Douglas Dieter to its Board of Directors
April 2, 2018
TSO3 Reports Fourth Quarter and Full Year 2017 Results
March 20, 2018
TSO3 Submits Response to US Regulators in Support of Terminal Sterilization of Duodenoscopes
March 19, 2018
TSO3's STERIZONE® VP4 Sterilizer Receives 510(k) Clearance for a Significant Enhancement
March 14, 2018
TSO3 Sets Fourth Quarter and Full Year 2017 Earnings Call for Wednesday, March 21, 2018 at 8: 30 a.m. EDT
March 7, 2018
TSO3 to Present at the RBC Capital Markets Healthcare Conference
February 14, 2018
TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America
January 25, 2018
TSO3 Provides an Operational Update
January 25, 2018
TSO3 Provides Duodenoscope Regulatory Filing Update
December 19, 2017
TSO3 Announces the Death of Mr. Jean Lamarre
November 27, 2017
TSO3 Provides Duodenoscope Regulatory Filing Update
November 16, 2017
TSO3 Reports Record Third Quarter 2017 Results
November 6, 2017
TSO3 Sets Third Quarter Earnings Call for Tuesday, November 7, 2017 at 8: 30 a.m. EST
October 25, 2017
TSO3 Duodenoscope Sterilization Technology to be Featured at the 18th World Federation for Hospital Sterilisation Sciences (WFHSS) Congress in Bonn, Germany
October 3, 2017
TSO3 Provides an Update on Regulatory Activity
September 27, 2017
Decks
The 5 newest of 41 decks. Every deck is listed under its year.
- Investor Presentation (May 2019)
Investor deck · 19 slides · May 2019
- Investor Presentation (May 2019)
Investor deck · 19 slides · May 2019
- Investor Presentation (November 2018)
Investor deck · 20 slides · November 2018
- Investor Presentation (November 2018)
Investor deck · 20 slides · November 2018
- Investor Presentation (May 2018)
Investor deck · 18 slides · May 2018